Sintilimab-induced autoimmune diabetes: A case report and review of the literature
Sign Up to like & getrecommendations! Published in 2022 at "World Journal of Clinical Cases"
DOI: 10.12998/wjcc.v10.i4.1263
Abstract: BACKGROUND With the widespread application of immune checkpoint inhibitor (ICI) therapy, the number of immune-related adverse effects (irAEs) has increased over the years. Autoimmune diabetes mellitus (DM) is a rare irAEs of ICIs and can… read more here.
Keywords: induced autoimmune; report; diabetes case; autoimmune diabetes ... See more keywords